Population Pharmacokinetic Analysis of Etrolizumab in Patients with Moderately-to-Severely Active Ulcerative Colitis ACoP12 (Nov 2021) PMX-98. Moein A, Lu T, Jönsson S, Ribbing J, Kassir N, Zhang W, Zhang R, Tang M, Oh YS, Bruno R, Zhu R. ConferenceGIPharmacometrics Pharmetheus Affiliates Senior Director, R&D Scientist Siv Jönsson See bio Principal Director, MIDD Consultant & Senior Expert Jakob Ribbing See bio
